From January 2018 to February 1, 31, the 2th Annual Capital Conference of Financing China 2 was held at Four Seasons Hotel Beijing, where nearly 2018 speakers and forum guests from governments, financial institutions, investment institutions, wealth management institutions, as well as listed companies, large enterprises and venture enterprises gathered together to discuss the trends and strategies of the equity investment industry in the new era.

On the evening of February 2, the annual meeting held the "2 China Equity Investment Comprehensive List Release and Award Ceremony". Dr. Jia Junxin, Chairman of New Value Capital, won the "2017 Top 2017 Outstanding Innovators in Chinese Equity Investment" award.

This award is undoubtedly a further recognition and affirmation of Dr. Jia's consistent investment philosophy. He said at the meeting that in the VC stage investment, professional personnel must conduct in-depth and thorough research on professional technologies, products and industry trends. Avoid using PE thinking and investment logic to evaluate and invest in start-up stage enterprises.

In addition, Dr. Jia remains optimistic about the future growth of China's capital markets, especially in high-tech industries such as artificial intelligence and biomedical industries. Therefore, New Value Capital has always focused on the investment and layout of the world's most cutting-edge technology start-ups, and the company has deployed industry experts and scientists to conduct professional research and in-depth analysis on the technology and industrialization application of artificial intelligence and biomedical industry, find high-quality enterprises, and create value for the society.

Financing China's 2017 China Equity Investment Outstanding Innovators Top30 (in musical order)